Petra Palkowitsch

511 total citations
12 papers, 383 citations indexed

About

Petra Palkowitsch is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Nephrology. According to data from OpenAlex, Petra Palkowitsch has authored 12 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Materials Chemistry and 3 papers in Nephrology. Recurrent topics in Petra Palkowitsch's work include Lanthanide and Transition Metal Complexes (7 papers), Advanced MRI Techniques and Applications (4 papers) and MRI in cancer diagnosis (3 papers). Petra Palkowitsch is often cited by papers focused on Lanthanide and Transition Metal Complexes (7 papers), Advanced MRI Techniques and Applications (4 papers) and MRI in cancer diagnosis (3 papers). Petra Palkowitsch collaborates with scholars based in Germany, United States and South Korea. Petra Palkowitsch's co-authors include Michael Forsting, Philipp Lengsfeld, Laura Schöckel, Hubertus Pietsch, Gregor Jošt, Peter Seidensticker, M A Bettmann, Claus D. Claussen, Koenraad J. Mortelé and Andreas F. Kopp and has published in prestigious journals such as European Radiology, Investigative Radiology and European Journal of Radiology.

In The Last Decade

Petra Palkowitsch

12 papers receiving 375 citations

Peers

Petra Palkowitsch
Wolf Gl United States
A. Alhassan Germany
B. Lundby Norway
Wendy Bottinor United States
S Matthew United Kingdom
Petra Palkowitsch
Citations per year, relative to Petra Palkowitsch Petra Palkowitsch (= 1×) peers Henrik S. Thomsen

Countries citing papers authored by Petra Palkowitsch

Since Specialization
Citations

This map shows the geographic impact of Petra Palkowitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Palkowitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Palkowitsch more than expected).

Fields of papers citing papers by Petra Palkowitsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Palkowitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Palkowitsch. The network helps show where Petra Palkowitsch may publish in the future.

Co-authorship network of co-authors of Petra Palkowitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Palkowitsch. A scholar is included among the top collaborators of Petra Palkowitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Palkowitsch. Petra Palkowitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schöckel, Laura, Gregor Jošt, Peter Seidensticker, et al.. (2020). Developments in X-Ray Contrast Media and the Potential Impact on Computed Tomography. Investigative Radiology. 55(9). 592–597. 79 indexed citations
2.
Michel, Alexander, Gabriel Chodick, Yingkai Cheng, et al.. (2018). Hypothyroidism in Young Children Following Exposure to Iodinated Contrast Media: An Observational Study and a Review of the Literature.. PubMed. 16(2). 256–265. 4 indexed citations
3.
Jick, Susan S., Monique M. Hedderson, Fei Xu, et al.. (2018). Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States. Investigative Radiology. 54(5). 296–301. 15 indexed citations
4.
Bhargava, Ravi, Gabriele Hahn, W. Hirsch, et al.. (2016). Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study. Pediatric Radiology. 46(9). 1317–1323. 27 indexed citations
5.
Prince, Martin R., Hae Giu Lee, Chang Hee Lee, et al.. (2016). Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. European Radiology. 27(1). 286–295. 32 indexed citations
6.
Shimada, Fumiki, et al.. (2013). Safety of Gadopentetate Dimeglumine after 120 Million Administrations over 25 Years of Clinical Use. Magnetic Resonance in Medical Sciences. 12(4). 297–304. 40 indexed citations
7.
Palkowitsch, Petra, et al.. (2013). Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiologica. 55(6). 707–714. 26 indexed citations
9.
10.
Forsting, Michael & Petra Palkowitsch. (2009). Prevalence of acute adverse reactions to gadobutrol—A highly concentrated macrocyclic gadolinium chelate: Review of 14,299 patients from observational trials. European Journal of Radiology. 74(3). e186–e192. 60 indexed citations
11.
Kopp, Andreas F., et al.. (2008). Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiologica. 49(8). 902–911. 66 indexed citations
12.
Palkowitsch, Petra & Matthias Voth. (2008). Summary of the safety data for Gadobutrol and Gadofosveset. 18(S5). 47–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026